• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Novavax(NVAX.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec12
FDA Plans to Issue 'Black Box' Warnings for COVID-19 Vaccines
10:30
Nov11
B. Riley Reaffirms Novavax 'Buy' Rating and Cuts Target Price
16:12
Nov6
Novavax released FY2025 9 Months earnings on November 6 Pre-Market (EST), actual revenue USD 976.34 M, actual EPS USD 2.3005
14:30
Novavax released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 70.45M (forecast USD 44.87M), actual EPS USD -1.25 (forecast USD -0.9167)
14:30
NovaVax Executives Forecast Significant Increase in Royalty Fees for 2026-2027 Flu Season
14:07
Novavax Reports Q3 EPS Loss of $1.25
13:52

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 70.45 M, Net Income -202.38 M, EPS -1.25

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 239.24 M, Net Income 106.51 M, EPS 0.6158

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 666.66 M, Net Income 518.65 M, EPS 2.9347

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TMDE
1.060
+139.28%
+0.617
UFG
1.360
+87.59%
+0.635
JCSE
1.990
+85.98%
+0.920
VRME
1.060
+57.13%
+0.385
MNTS
8.820
+53.66%
+3.080
LHSW
0.8400
+53.42%
+0.292
DVLT
1.440
+42.57%
+0.430
PXIU
2.400
+40.35%
+0.690
INBS
11.000
+39.42%
+3.110
CELG.RT
0.1100
+38.02%
+0.030
View More